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Summary
How are phosphorylated kinases transported over
long intracellular distances, such as in the case of
axon to cell body signaling after nerve injury? Here,
we show that the MAP kinases Erk1 and Erk2 are
phosphorylated in sciatic nerve axoplasm upon nerve
injury, concomitantly with the production of soluble
forms of the intermediate filament vimentin by local
translation and calpain cleavage in axoplasm. Vimen-
tin binds phosphorylated Erks (pErk), thus linking
pErk to the dynein retrograde motor via direct binding
of vimentin to importin . Injury-induced Elk1 activa-
tion and neuronal regeneration are inhibited or de-
layed in dorsal root ganglion neurons from vimentin
null mice, and in rats treated with a MEK inhibitor or
with a peptide that prevents pErk-vimentin binding.
Thus, soluble vimentin enables spatial translocation
of pErk by importins and dynein in lesioned nerve.
Introduction
How are kinase signals propagated over long distances
within a cell? This fundamental question in cell biology
is especially acute in the case of neurons, which are
highly polarized and differentiated cells with axonal and
dendritic processes that extend over distances of milli-
meters to meters in large mammals. Local generation
of signal in an axon or dendrite by phosphorylation of
a signaling kinase must be followed in many cases by
propagation of the signal back to the cell body and the
nucleus. Quantitative theoretical analyses have shown
that under typical protein diffusion rates and cytosolic
phosphatase activity levels, activated MAP kinases
should be dephosphorylated to basal levels within a
few microns of the site of activation (Kholodenko,
2003), unless the signal is protected or regenerated en
route. A number of possibilities have been suggested,
including lateral propagation from kinase to kinase at
the cell surface (Reynolds et al., 2003), formation of
multivesicular bodies that package the phosphorylated
kinase (Weible and Hendry, 2004), or generation of sig-
naling endosomes containing both ligand and receptor
(Howe and Mobley, 2004). Despite this diversity of po-
tential mechanisms for membrane-associated signals,
to date there is no experimental data demonstrating
how a kinase signal might be transported over long in-*Correspondence: mike.fainzilber@weizmann.ac.iltracellular distances in nonvesiculated signaling com-
plexes.
Retrograde injury-signaling mechanisms in lesioned
nerve provide an intriguing example of a nonvesicu-
lated long-distance signaling complex. Mammalian pe-
ripheral and invertebrate central nerves are capable of
functional regeneration, in part due to intrinsic mecha-
nisms activated in the neuronal cell body (Goldberg,
2003). The cell body response can be triggered or en-
hanced by protein injury signals retrogradely trans-
ported from lesion sites (Perlson et al., 2004a). We have
recently shown that injury-induced regulation of impor-
tins in axons provides a mechanism for retrograde sig-
naling after lesion, due to a constitutive interaction of
importin α with dynein. The signaling is thought to de-
pend on endogenous regeneration-modulating proteins
that utilize the nuclear localization signal (NLS) binding
site of the importins for retrograde transport (Hanz et
al., 2003).
The precise identity of the NLS-bearing retrograde
signals is still unknown, but others have implicated a
MAP kinase Erk1/2 homolog in retrograde injury signal-
ing in Aplysia neurons (Sung et al., 2001). Nuclear im-
port of most Erk family members is not dependent on
classical NLS binding to importin α/β heterodimers
(Whitehurst et al., 2002). Do activated MAP kinases ac-
cess the same retrograde injury-signaling mechanism?
We used differential proteomics as a nonbiased method
to seek out components of the system and identified
soluble cleavage products of an intermediate filament
(IF) protein as a major component of the retrograde pro-
tein ensemble after nerve lesion in a mollusk (Perlson
et al., 2004b). Truncation mutants of the closely related
mammalian type III IF vimentin can translocate from cy-
toplasm to nucleus in transfected cells (Rogers et al.,
1995). Moreover, vimentin is known to interact with sig-
naling molecules (Paramio and Jorcano, 2002). We
therefore examined potential roles of mammalian type
III intermediate filaments in retrograde injury signaling
in the sciatic nerve and in neurons of the dorsal root
ganglia (DRG). Here, we show that vimentin expression
is elevated in sciatic nerve axoplasm after injury. Vi-
mentin links pErk to importin β in the retrograde injury-
signaling complex and enables retrograde transport of
activated MAP kinases in sensory axons.
Results
The molluscan IF identified in our proteomics screen
was found to be most homologous to the vertebrate
type III IF vimentin (Figure 1A). In the nervous system,
vimentin is most prominently expressed in glial cells
(Menet et al., 2003), but it is also expressed in neurons
early in development and following injury, where it has
been suggested to play a role in early generation and
extension of neurites (Boyne et al., 1996; Dubey et al.,
2004). peripherin is another closely related type III IF
that is highly expressed in peripheral nerve axons and
upregulated by injury (Lariviere and Julien, 2004). We
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716Figure 1. Vimentin and Peripherin Are Upreg-
ulated in Axoplasm after Nerve Injury
(A) A phylogenetic tree constructed using
ClustalX reveals the evolutionary relatedness
of vertebrate vimentin and other type III in-
termediate filaments to the Lymnaea inter-
mediate filament RGP51.
(B) Immunostaining of adult wild-type and vi-
mentin−/− DRG neurons after 2 days in cul-
ture reveals expression of vimentin (red) in
the wild-type but not in the vimentin−/− neu-
rons, and β-gal (blue) in vimentin−/− but not
in wild-type. Colocalization with the axonal
marker NFH (green) showed vimentin ex-
pression in both cell body and neurites. Cell
counts revealed that 64% of the wild-type
NFH-positive neurons expressed vimentin,
while 58% of the vimentin−/− neurons ex-
pressed β-gal. Scale bar, 20 m.
(C) Western blot analysis of postlesion axo-
plasm reveals upregulation of vimentin and
peripherin. Adult rats were anesthetized and
subjected to sciatic nerve crush, and axo-
plasm was obtained from nerves dissected
at the indicated times postlesion. Aliquots
(40 g) of axoplasm were analyzed by West-
ern blot and quantified in reference to the
level of vimentin and peripherin at 6 hr. Cal-
peptin (100 M), cycloheximide (10 g/ml),
or actinomycin-D (5 g/ml) was applied to
the nerve by injection concomitantly with the
injury. β-tubulin was used to confirm equal
loading. The quantification is in percent of
protein levels at 6 hr postlesion (averages ±
standard deviation; n = 3).examined the expression of vimentin or peripherin in j
wthe sciatic nerve and DRG and observed vimentin
immunostaining in the cell body and processes of ap- (
oproximately 60% of adult wild-type NFH-positive sen-
sory neurons in culture (Figure 1B). A corresponding f
Tfraction of vimentin null neurons stained positively for
β-galactosidase (β-gal), thus confirming expression of d
othe vimentin locus after lesion. We then examined oc-
currence of both IFs in sciatic nerve axoplasm in vivo, s
vafter verifying purity of the axoplasm preparations by
lack of immunoreactivity for S100 and RCC1 (data not p
tshown), as well as lack of other glial or nuclear markers
(see Figure S1 in the Supplemental Data available with l
cthis article online). Little or no IF was found in axoplasm
before injury, but within 30 min of a lesion we observed m
vthe appearance of soluble forms of both vimentin and
peripherin (Figure 1C). Levels of these proteins in- t
Dcreased during 8 hr following injury, and it was possible
to block the increase by injecting the nerve with cyclo- p
pheximide (CHX), an inhibitor of translation, but not with
actinomycin-D (ACTD), an inhibitor of transcription. The p
tlower molecular masses of both IFs were lost upon
treatment of the nerve with the calpain inhibitor calpep- o
Ntin. Addition of calpeptin to already extracted axoplasm
had no effect on the vimentin pattern observed (data r
dnot shown). Thus, soluble forms of vimentin and periph-
erin are produced in injured sciatic nerve axoplasm by M
ga combination of local translation and calpain cleav-
age activity. 2
nWe then examined coimmunoprecipitation of vimen-
tin or peripherin with the dynein motor complex in in- nured nerve. Vimentin was observed to coprecipitate
ith dynein in increasing amounts with time after injury
Figure 2A). In contrast, peripherin was not found in any
f the precipitates, despite the high levels of peripherin
ound in axoplasm at these time points (see Figure 1C).
he increased amounts of vimentin coprecipitating with
ynein over time after injury are a direct consequence
f the increasing amounts of vimentin and importin β,
ince analyses of precipitated over input levels re-
ealed similar pull-down efficiency at the different time
oints (data not shown). As reported previously, impor-
in α4 was found in the complex in both uninjured and
esioned nerve, while importin β levels increased in the
oprecipitate after injury (Figure 2A). Reciprocal coim-
unoprecipitations with an antibody directed against
imentin revealed increasing amounts of dynein, impor-
in α, and importin β with time after injury (Figure 2B).
oes vimentin access the NLS binding site in the com-
lex? We addressed this issue by conducting copreci-
itation experiments of dynein with vimentin in the
resence of excess NLS peptide or reverse-NLS pep-
ide as control. As shown in Figure 2C, the interaction
f vimentin with dynein is not competed by excess
LS. Silver staining of 2D-PAGE from such pull-downs
evealed other protein spots that are displaced from the
ynein complex by NLS peptide (data not shown).
oreover, vimentin coprecipitates from axoplasm to-
ether with the importins in NLS pull-downs (Figure
D), indicating that a vimentin-importin interaction can-
ot be mediated via the NLS binding site. A number of
onclassical importin cargoes undergo nuclear uptake
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717Figure 2. Vimentin Interacts with the Dynein/Importin Complex after Nerve Injury
(A) Vimentin, importin β, and importin α but not peripherin were coprecipitated with dynein from axoplasm (500 g input per lane) at 0–6 hr
postlesion. (B) Dynein, importin β, and importin α were coprecipitated with vimentin at the indicated times postlesion. Quantification in both
(A) and (B) is in reference to protein levels at 6 hr postlesion (averages ± standard deviation; n = 3). (C) Coprecipitation of vimentin with dynein
was not affected by coincubation with NLS or reverse-NLS (REV) peptides at 2 M concentration. “C,” axoplasm from control nerve; “I,”
axoplasm from injured nerve 6 hr postlesion. (D) Vimentin coprecipitates in an NLS pull-down assay. Biotinylated NLS peptide (30 g) was
injected to sciatic nerve before extraction of axoplasm, and an additional 5 g peptide was added to 0.5 mg axoplasm protein and incubated
for 1 hr at room temperature, followed by pull-down on streptavidin dynabeads. Proteins were eluted with 0.1% TFA and subjected to Western
blot analysis. (E) Direct interaction of importin β and vimentin in vitro. GST-importin β (1 g) was incubated with vimentin (0.1 g) for 2 hr at
37°C before GST pull-down. GST alone was used as a negative control. The experiments in (C)–(E) were each repeated at least three times
with similar results. (F) GST-importin β (1 g) was incubated with axoplasm (500 g) from 0–6 hr postlesion for 2 hr at 37°C. The pull-down
revealed coprecipitation of vimentin but not peripherin. Quantification of pulled-down vimentin is shown in reference to protein levels at 6 hr
postlesion (averages ± standard deviation; n = 3).by direct binding to importin β (Harel and Forbes, 2004).
We therefore tested for a direct interaction of vimentin
with importin β by in vitro coprecipitation of vimentin
with a GST-importin β fusion protein. Purified recombi-
nant vimentin was readily pulled down with GST-impor-
tin β but did not precipitate with GST alone (Figure 2E).
Finally, GST-importin β was incubated with axoplasm
from different times after lesion, and Western blots of
pull-downs were probed for both vimentin and periph-
erin. As shown in Figure 2F, increasing amounts of vi-
mentin were found in the pull-downs in correlation with
time after lesion, whereas peripherin could not be de-
tected at any of the time points examined.
Having established that soluble forms of vimentin in-
teract with the importin-dynein retrograde complex af-
ter nerve injury, we wished to determine the role of this
intermediate filament molecule in the complex. Vimen-
tin has been suggested to act as a scaffold or carrier
for signaling molecules (Paramio and Jorcano, 2002) or
to directly modulate nuclear architecture and/or tran-
scription (Traub and Shoeman, 1994). The Aplysia data
implicating Erk-like kinases in retrograde injury signal-
ing (Sung et al., 2001) suggested that vimentin might
act as a scaffold for the retrograde transport of Erks in
mammalian nerve. We therefore examined the activa-
tion of MAP kinases in lesioned rat sciatic nerve and
observed phosphorylation of axoplasmic Erk1/2 within
30 min and lasting at least 8 hr after injury (Figure 3A).
Immunoprecipitation of either vimentin or dynein from
axoplasm revealed coprecipitation of pErk increasing
with time after lesion (Figure 3B). Incubation of recom-
binant GST-pErk2 with axoplasm from different time
points after lesion revealed coprecipitation of increas-ing amounts of vimentin but not peripherin (Figure 3C).
We then examined retrograde transport of vimentin and
pErk after sciatic nerve lesion in vivo. Crushed nerves
from adult rats at increasing times after lesion were di-
vided into consecutive segments as shown in Figure
4A. Axoplasm from each segment was subjected to dy-
nein immunoprecipitation, and precipitates were then
analyzed by Western blot for presence of vimentin and
pErk. Both molecules moved retrogradely together with
dynein over the time course of the experiment, arriving
at the L4/L5 DRGs approximately 20 hr after the lesion.
Interestingly, vimentin remained associated with dynein
up to the 24 hr time point in the DRG, whereas the pErk
was not found in the complex shortly after arrival in
the ganglia (Figure 4A), thus potentially freeing the MAP
kinase for interaction with cytoplasmic or nuclear sub-
strates in the cell body. Erks modulate gene expression
by directly phosphorylating transcription factors such
as the ETS domain factor Elk1. We therefore examined
the time course of Elk1 phosphorylation in L4/L5 DRG
after sciatic nerve lesion in adult rats. Two peaks of
Elk1 phosphorylation were observed in DRG lysates: an
initial, very rapid event that may be in response to
membrane depolarization caused by the crush and a
second, more sustained phosphorylation that com-
mences upon arrival of pErk in the ganglia (Figure 4B).
We verified that the later phosphorylation event indeed
occurs in neurons by immunostaining of L4/L5 ganglion
sections for NFH and pElk1. As shown in the right panel
of Figure 4B, phosphorylated Elk1 is concentrated in
nuclei of NFH-positive neuronal cell bodies 24 hr after
sciatic nerve lesion.
The discrepancy between dissociation times of vi-
Neuron
718Figure 3. Vimentin Interacts with pErk in Lesioned Nerve F
(A) Western blot analysis of 40 g aliquots of axoplasm from 0 to 8 (
hr postlesion reveals phosphorylation of Erk1 and Erk2 after injury. 3
Reprobing of the blot with a general Erk antibody was used to con- s
trol for equal loading. Quantification is in percentage of pErk levels i
at 6 hr postlesion (average ± standard deviation; n = 3). t
(B) Immunoprecipitation of dynein or vimentin from 500 g axo- r
plasm taken at 0–6 hr postlesion shows an increase in coprecipitat- a
ing pErk with time. The quantification is in reference to coprecipi- v
tating pErk levels at 6 hr postlesion (average ± standard deviation; n
n = 3). General Erk and dynein were used as loading controls (40 G
g protein per lane). d
(C) GST-pErk pull-down from axoplasm 0–6 hr postlesion reveals n
coprecipitation of vimentin but not peripherin. The quantification (
shows coprecipitating vimentin as percent of maximum (aver- (
ages ± standard deviation; n = 3). The GST-pErk (0.5 g) was incu- l
bated with 500 g of axoplasm protein obtained at the indicated E
postlesion times. General Erk and dynein were used as loading (
controls, and axoplasm levels of vimentin and importin β are also t
shown for comparison (40 g axoplasm protein per lane). Rigure 4. Retrograde Transport of Vimentin and pErk
A) Coimmunoprecipitation of vimentin and pErk with dynein from
00 g aliquots of axoplasm obtained from lesioned sciatic nerve
egments I–III and DRG extract IV as indicated in the schematic. I
ndicates the segment adjacent to the lesion site. The DRG extrac-
ion (IV) was in lysis buffer. Sampling at 0–24 hr postlesion revealed
etrograde movement of both pErk and vimentin with dynein until
rrival in the DRG at 20 hr postlesion. At the 24 hr time point, only
imentin was still found in association with dynein in the DRG. Dy-
ein was used as a loading control for all lanes in the time series.
raphs to the right of each set of gels quantify the corresponding
istribution of dynein-associated vimentin and pErk along the
erve as percent of maximum (average ± standard deviation; n = 4).
B) Phosphorylation of Elk1 in L4/L5 DRGs from the experiment of
A). (Left) Aliquots (50 g) of DRG lysates from the indicated post-
esion times (hr) were analyzed by Western blot for pElk1. General
rk was used as the loading control (50 g total protein per lane).
Right) Immunostaining of a DRG cross-section 24 hr postlesion for
he neuronal marker NFH (green) and pElk1 (red). Scale bar, 50 m.
epeated three times with similar results.imentin and pErk from the dynein complex upon arrival
at the ganglia suggested differential regulation of these i
ctwo interactions. Nerve injury is known to cause a sig-
nificant increase in intracellular calcium levels in axons c
o(Mandolesi et al., 2004). We therefore tested the effects
of calcium on the pErk-vimentin and vimentin-importin mnteractions and found that vimentin binding to pErk2
n vitro was calcium dependent, increasing at calcium
oncentrations of up to 1 M (Figure 5A). In contrast,
hanging calcium concentrations had little or no effect
n the vimentin-importin β interaction. Similar experi-
ents with nonphosphorylated Erk2 revealed that bind-
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Phosphorylation
(A) GST-pErk (0.5 g) or GST-importin β (1 g) was incubated with
vimentin (0.1 g) in NTB with the indicated calcium concentrations
or with 2 mM EGTA for 2 hr at 37°C. GST alone was used as nega-
tive control. The gel standard (Std) is 50 ng vimentin. Quantification
is shown as percent of input vimentin (average ± standard devia-
tion; n = 3).
(B) Concentration-dependent phosphatase protection of pErk by
vimentin. Importin β (2 g) was incubated with GST-pErk (0.1 g)
and with the indicated amounts (g) of vimentin or neurofilament
(NF) for 2 hr in NTB containing 1 M calcium at 37°C. Alkaline phos-
phatase (AP; 2 U) or axoplasm from injured nerve 6 hr postlesion
(AX; 100 g) was added for an additional 30 min before performing
GST pull-down followed by Western blotting for pErk. Vimentin pro-
tected pErk from dephosphorylation in a concentration-dependent
manner. The gel standard (Std) is 20 ng GST-pErk. Quantification
is shown as percent of input pErk (average ± standard deviation;
n = 3).
(C) Phosphatase protection of pErk by vimentin is calcium depen-
dent. The experiment was carried out as described in (B) at a single
concentration (2 g) of vimentin or NF and at the indicated concen-
trations of calcium or 2 mM EGTA. Note that calcium dependence
of the phosphatase protection parallels the calcium dependence of
vimentin-pErk binding shown in (A).ing of nonphosphorylated Erk to vimentin is reduced at
high calcium concentrations (data not shown). There-
fore, another possible explanation for the apparent
dissociation of pErk in the cell body might be de-
phosphorylation of the kinase. We examined this issue
by testing the effects of increasing concentrations of
vimentin on Erk phosphorylation in the presence of al-
kaline phosphatases (APs) or of sciatic nerve axo-
plasm. Strikingly, vimentin levels in the range of 3-fold
to 6-fold molar ratio of vimentin to pErk provided al-
most complete in vitro protection of pErk2 from the
phosphatases, while similar levels of neurofilament (NF)
had no effect (Figure 5B). The protection of pErk by
vimentin was specific, as identical concentrations of vi-
mentin had no effect on hydrolysis of p-nitrophenyl
phosphate (pNPP) by AP (data not shown). The calcium
dependence of pErk binding to vimentin prompted us
to examine if the in vitro phosphatase protection pro-
vided by vimentin could also be modulated by calcium.
As shown in Figure 5C, vimentin protected pErk2 from
dephosphorylation in vitro in a calcium-dependent
manner, and in the same range of calcium concentra-
tions that support pErk-vimentin binding.
The data described thus far indicate that soluble
forms of vimentin interact with the importin-dynein ret-
rograde complex in injured rat sciatic nerve and thereby
enable transportation of pErk from the lesion site to ac-
tivate substrates such as Elk1 in neuronal cell bodies.
We tested these findings by comparing immunoprecipi-
tates of dynein from sciatic nerve axoplasm of wild-
type and vimentin−/− mice. The pErks coprecipitated
with dynein in injury axoplasm from wild-type mice but
not from vimentin nulls (Figure 6A). Injury-induced Erk
phosphorylation was similar in wild-type and vimentin−/−
axoplasm; thus, the specific difference was the lack of
interaction of pErk with the dynein complex in vimentin
null animals. We then examined retrograde accumula-
tion of p-Erk in a lesion-ligation paradigm in sciatic
nerves of wild-type versus vimentin null mice. As
shown in Figure 6B, pErk accumulated retrogradely at
the ligation site in wild-type but not in vimentin−/− sci-
atic nerve. Erk and Elk1 phosphorylation were subse-
quently examined in ganglia from wild-type or vimen-
tin−/− mice, after lesion of the nerve close to the entry
points to the DRG (Figure 6C). In these experiments,
phosphorylated Erks appeared in wild-type ganglia
from 10 min after the crush, and Elk1 phosphorylation
kinetics was similar to that of the Erks. In contrast, gan-
glia from vimentin−/− mice exhibited little or no Erk or
Elk1 phosphorylation over the time course of these
experiments (Figure 6C). Because Western blots of
ganglia were by necessity conducted from whole gan-
glion lysates, we verified that the observed Elk1 phos-
phorylation occurs within neurons by immunostaining
of ganglion sections. As shown in Figure 6D, Elk1 phos-
phorylation is concentrated in nuclei of NFH-positive
neuronal cell bodies from wild-type animals but is not
observed in corresponding neurons from vimentin nulls.
In order to assess the contribution of pErk and vi-
mentin to the cell body response to injury, we pro-
ceeded to examine in vitro regenerative outgrowth of
adult DRG neurons from vimentin−/− mice. Neurite out-
growth from vimentin−/− cells 48 hr in culture was signif-
icantly reduced compared to wild-type neurons, and
Neuron
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(A) pErk does not coprecipitate with dynein in sciatic nerve axoplasm from vimentin−/− mice. Aliquots (300 g) of axoplasm from control and
6 hr postlesion nerve were subjected to dynein immunoprecipitation followed by Western blots for the indicated components. Note that,
although Erk phosphorylation is comparable in axoplasm of wild-type and vimentin−/− mice, there is no interaction of pErk with the dynein
complex in vimentin−/− mice. This experiment was repeated three times with similar results.
(B) Retrograde accumulation of pErk at a ligation site in injured sciatic nerve. Sciatic nerves of wild-type and vimentin−/− mice underwent
crush lesion and ligation between the lesion site and the ganglia. At the indicated times, nerves were removed and sectioned longitudinally
over the ligation area before staining for NFH (green) and pErk (red). Sections are shown oriented so that the lesioned side is to the left, and
the ligation is on the right. Scale bars are 100 m for the time series and 10 m for the higher-magnification zoom panel. Note that pErk
accumulates at the ligation site in wild-type nerve but not in the vimentin nulls. This experiment was repeated twice with equivalent results.
(C) pErk and pElk1 activation in mouse DRG. DRG processes were lesioned approximately 1 mm from the ganglia. After incubation for the
indicated times, ganglia were lysed and subjected to Western blot analyses as shown. Concomitant activation of pErk and pElk1 was
observed in ganglia from wild-type but not from vimentin−/− mice. The quantification is percent of maximum, average ± standard deviation of
three experiments.
(D) Cross-sections of ganglia from the experiment described in (C) immunostained for NFH (green) and pElk1 (red) show pElk1 activation in
wild-type but not vimentin null neurons. Scale bar, 50 m.the difference was even more pronounced when com- s
gparing only the β-gal-positive neurons from the knock-
out to vimentin-positive neurons from wild-type mice t
1(Figures 7A and 7B). There was no observable differ-
ence in outgrowth capacity of vimentin null/β-gal-nega- n
itive neurons as compared to wild-type/vimentin-nega-
tive neurons. Trituration of vimentin null neurons with t
pcalpain-treated recombinant vimentin rescued the out-
growth deficit in β-gal-positive cells and had no effect m
pon neurons that did not express β-gal, as shown by
comparing outgrowth of β-gal-expressing neurons (those e
toriginally destined to express vimentin) with similar cells
from the same ganglia that did not express β-gal (Fig- i
mures 7A, 7B, and S2A). We examined the capacity of
calpain-treated vimentin for polymerization by compar- t
ling pelleted versus soluble vimentin after ultracentrifu-
gation (Figure S2B) and by comparative observation of (
avimentin filaments by electron microscopy (Figure S2C).
Both assays showed that calpain-treated vimentin was r
not capable of polymerizing into filamentous struc-
tures; thus, the outgrowth rescue activity obtained by i
strituration of the protein cannot be due to cytoskeletal
roles of vimentin. t
(DRG neurons undergo a transcription-dependentwitch from arborizing to long-distance neurite out-
rowth upon peripheral axotomy by a previous (condi-
ioning) lesion of the sciatic nerve (Smith and Skene,
997), and this effect is mediated by the retrograde sig-
aling complex (Hanz et al., 2003). We therefore exam-
ned the conditioning lesion response in DRG of vimen-
in−/− mice. Sciatic nerve crush was performed 3 days
rior to culture of neurons from the L4/L5 DRGs of vi-
entin null and wild-type mice. After 18 hr in culture,
relesioned conditioned neurons from wild-type mice
xtended neurites that were on average 2-fold longer
han those of naive controls (Figures 7C and 7D). A sim-
lar effect was observed in neurons from vimentin null
ice that did not express β-gal. In contrast, β-gal-posi-
ive neurons from vimentin−/− DRG did not extend
onger neurites as a result of the conditioning crush
Figures 7C and 7D). Thus, both in vitro and in vivo,
vimentin-mediated signal facilitates the regenerative
esponse of DRG neurons.
In order to ask whether the vimentin-mediated signal
s pErk, we tested a series of synthetic peptides de-
igned to mimic surface-exposed regions of Erk for
heir capacity to interfere with pErk-vimentin binding
Figure 7E). Out of five peptides examined in this way, a
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tion Responses to Vimentin and pErk
(A and B) Comparison of outgrowth of adult
mice DRG neurons after 48 hr in culture.
Green indicates immunostaining for NFH,
and red indicates vimentin (wild-type) or
β-gal (vimentin−/−). Each row includes two
panels with predominantly vimentin- or β-gal-
positive cells and two panels with cells pre-
dominantly negative for these markers. The
third (lower) row shows vimentin−/− neurons
triturated with calpain-cleaved vimentin (6.7
g per ganglion) before plating. Quantifica-
tion of three independent experiments is
shown in (B), measuring at least 250 cells per
experiment (average ± standard error of
mean). Significant differences are revealed in
neurite outgrowth between the vimentin null
and wild-type neurons in the total population
(p < 0.05). These differences are even more
pronounced when comparing vimentin-posi-
tive to β-gal-positive neurons (p < 0.01),
while there was no difference between wild-
type vimentin-negative and vimentin null
β-gal-negative cells. Trituration of calpain-
treated vimentin to vimentin null neurons be-
fore plating enhanced the outgrowth of
β-gal-positive cells and had no effect on
cells that did not express the β-gal marker.
Vimentin uptake after trituration was verified
by immunostaining, and we analyzed only
those cultures in which over 50% of the cells
contained vimentin 3 hr after trituration. Tri-
turation of calpain-treated neurofilament had
no effect, and calpain-treated vimentin was
found to be incapable of polymerization (Fig-
ure S2). Scale bar, 50 m.
(C and D) Effects of sciatic nerve conditional
lesion in vimentin−/− mice. Sciatic nerves
were crushed as described, and L4/L5 DRG
neurons were cultured 3 days after the con-
ditioning lesion. Neurons were fixed after 18
hr in culture and stained, and neurite out-
growth was measured. Wild-type neurons
and vimentin null neurons negative for β-gal
revealed accelerated neurite outgrowth after
a conditioning crush (>100 neurons measured from two independent experiments; p < 0.01), whereas no change was observed in vimentin
null β-gal-positive cells (250 neurons measured from two independent experiments; average ± standard error of mean). Scale bar, 100 m.
(E) Effects of five Erk-derived synthetic peptides (sequences shown on the left) on the interaction of vimentin with pErk. Five different peptides
were incubated with vimentin (20:1 molar ratio) in PBS for 2 hr at 37°C, followed by GST-pErk pull-down. A single peptide designated Erk89
clearly inhibits pErk-vimentin binding, and the inhibition was shown to be concentration dependent. This experiment was repeated three
times with similar results.
(F and G) Effects of the MEK inhibitor UO126 and the Erk89 peptide on conditioning lesion responses in adult rat DRG neurons. Sciatic nerves
were injected with 10 M UO126 or 250 g of Erk89 or Erk312 peptides, concomitantly with a conditioning crush injury. Five days after the
lesion, L4/L5 DRG neurons were cultured in vitro for 18 hr, fixed, and stained for NFH before measurement of neurite outgrowth. Both the
percentage of sprouting neurons (n = 300 for each treatment; p < 0.01) and the neurite length in those that did sprout (n > 60 for each
treatment; p < 0.05) were significantly reduced by UO126 or Erk89, whereas the Erk312 peptide had no effect. The experiment was repeated
three times with two animals for each treatment, totaling six independent animal assays for each treatment (average ± standard error of
mean). Scale bar, 100 m.
(H) Recovery of sensory responses after lesion of the sciatic nerve in vivo. Wild-type and vimentin null mice (14 animals in each group)
underwent sciatic nerve lesion and were then monitored daily for up to 30 days postlesion. At each monitoring session, the animal’s response
to toe pinch was tested for each individual digit, and the response was plotted as percent of responding digits. There was an immediate and
essentially complete cessation of response in both groups of animals immediately after the lesion, with a clear difference in recovery kinetics
between wild-type and vimentin null animals. GAP43 immunostaining was performed to compare (AU, arbitrary units) regeneration in longitudi-
nal sections totaling 1 cm nerve length adjacent to the lesion site. This analysis revealed significant differences between wild-type and
vimentin null nerves 6 days after lesion (average ± standard deviation). Scale bar, 100 m.single peptide designated Erk89 (numbering is the first
residue of the peptide as found in human Erk2) was
found to inhibit vimentin-pErk binding in a concentra-
tion-dependent manner. We therefore tested the effects
of the Erk89 in comparison with another one of the pep-tides on the conditioning lesion response in adult rats.
In parallel experiments, we also examined the effects
of the MEK inhibitor UO126. The peptides or the inhibi-
tor were injected into sciatic nerve concomitantly with
a conditioning sciatic nerve crush, and outgrowth of
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UO126 and Erk89 significantly inhibited the condition- p
ing lesion response in rat DRG neurons, whereas the r
Erk312 peptide had no effect (Figures 7F and 7G). The c
UO126 results show that pErk is required for efficient v
retrograde injury signaling, and the effects of the Erk89 2
peptide indicate that vimentin-pErk binding is neces- s
sary for the process. Taken together with the results s
obtained from vimentin null mice, this series of experi- b
ments proves that vimentin-mediated retrograde trans- i
port of pErk facilitates the cell body response in the f
sciatic nerve-DRG system. b
Finally, we examined the effects of vimentin on sen- k
sory neuron regeneration in vivo. Sciatic nerve crush i
was carried out on 14 wild-type and 14 vimentin−/− i
mice, followed by daily monitoring of responses to toe t
pinch for up to 30 days postlesion. As shown in Figure v
7H, there was an immediate and essentially complete t
cessation of sensory response in both groups immedi- c
ately after the lesion. Recovery of sensation was de- m
layed in the vimentin null animals as compared to wild- s
type, with full recovery observed after 11 days in null a
animals compared to 1 week in wild-type. Quantifica- c
tion of regenerative sprouting by GAP43 immuno-
staining of longitudinal sections revealed significant Pdifferences between wild-type and vimentin null nerves
T3–9 days after lesion (Figure 7H and data not shown).
pThus, lack of vimentin causes a marked delay in the in
tvivo regeneration of sensory axons in sciatic nerve.
n
aDiscussion
e
aWe have shown that vimentin is upregulated in sciatic
vnerve axoplasm after lesion and is transported in the
lretrograde injury-signaling complex via a direct interac-
ftion with importin β. The MAP kinases Erk1 and Erk2
2are phosphorylated in axoplasm after nerve lesion, and
rvimentin binds phosphorylated Erks, thus linking them
(to the retrograde transport system (Figure 8). These
rfindings reveal how non-NLS-bearing signaling mole-
ecules can access the importins-mediated retrograde
ctransport complex, describe an additional role for inter-
amediate filaments, and define a mechanism that allows
vlong-distance kinase signaling within cells.
d
sRecruitment of Vimentin to the Retrograde
bTransport Machinery
cA critical initiating event for the mechanism outlined
above is local axonal synthesis of both importin β and aFigure 8. A Model for Vimentin-Dependent
Retrograde Transport of Phosphorylated
MAP Kinases
Local synthesis of vimentin at the axonal
lesion site (left), together with phosphoryla-
tion of Erk (yellow), allows linkage of pErk to
the retrograde complex via a direct interac-
tion of vimentin with importin β. The complex
may protect pErk from phosphatases due to
steric hindrance, and pErk should remain
bound to vimentin as long as the complex is
within a high-calcium microenvironment.
Upon arrival in the cell body, pErk dissoci-
ates from vimentin and is then available to
downstream targets in the cell body or the
nucleus.imentin at the lesion site. Recently, it has become ap-
arent that local axonal translation occurs for a wide
ange of gene products, contributing to diverse pro-
esses of growth cone navigation in the embryonic ner-
ous system or regeneration in the adult (Giuditta et al.,
002). Thus, local translation of specific axonal tran-
cripts provides a versatile mechanism activating latent
ignaling mechanisms. Indeed, local translation might
e a prerequisite for vimentin participation in retrograde
njury signaling, as anterograde transport of the protein
rom the cell body may be diverted to filament assem-
ly en route (Prahlad et al., 1998). vimentin mRNA is
nown to be targeted to specific subcellular locations
n nonneuronal cells (Morris et al., 2000), and it will be
nteresting to determine how vimentin message is
argeted to axons. In this context, it is noteworthy that
imentin synthesis at an axonal lesion site introduces
he nascent protein chain directly into an elevated
alcium environment likely to be unfavorable for fila-
ent assembly. High calcium may inhibit filament as-
embly due to vimentin phosphorylation by calcium-
ctivated CAM kinase II (Inagaki et al., 1997), or due to
alpain-mediated cleavage of vimentin.
otential Regulatory Roles for Calcium
he in vitro effects of calcium on pErk binding, and
hosphatase protection, suggest that calcium eleva-
ion in the nerve is likely to influence the retrograde sig-
al. Calcium is elevated in axons of both invertebrates
nd vertebrates after nerve injury or trauma (Mandolesi
t al., 2004; Ziv and Spira, 1995). Although recovery of
xonal calcium to basal levels can be fairly rapid in in-
ertebrate neurons in culture (Ziv and Spira, 1995),
evels in injured mammalian nerve may remain elevated
or prolonged periods (Iwata et al., 2004; Wolf et al.,
001). This might be due to delayed sealing caused by
educed extracellular calcium in the mammalian system
Shi et al., 2000; Yoo et al., 2003), or due to different
ates of sealing in axons of different diameters (Howard
t al., 1999). Thus, an axonal lesion may lead to signifi-
ant and prolonged elevation of calcium levels in the
xon, thereby facilitating the interaction of pErk with
imentin. If the injury is severe, axonal sealing may be
elayed, and calcium elevation might be maintained for
ufficient time for the pErk signal to arrive at the cell
ody. If the injury is relatively mild and axon sealing and
alcium recovery is rapid, pErk may dissociate before
rrival at the cell body.
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for Intermediate Filaments
Our data reveal unexpected roles for vimentin that are
not necessarily related to its functions in cytoskeleton
formation. Initial studies on vimentin null mice showed
that they survive and breed normally (Colucci-Guyon et
al., 1994). Subsequent analyses revealed subtle defects
in cerebellar glia (Gimenez y Ribotta et al., 2000), neuro-
behavioral effects (Lalonde and Strazielle, 2003), and
impaired skin wound healing due to mesenchymal de-
fects (Eckes et al., 2000); thus, vimentin is important in
a range of cell types. A recent study has shown re-
duced astroglial reactivity and increased plastic sprout-
ing of supraspinal axons in hemisected spinal cord of
vimentin/GFAP double null mice (Menet et al., 2003).
This phenotype was attributed to a reduction of the in-
hospitable environment that would normally be gener-
ated by astrocytes at the lesion site. The outcome of
vimentin perturbation in nerve injury is therefore likely
to depend on the balance between its regeneration-
enhancing contribution to intrinsic growth mechanisms
via retrograde axonal signaling versus an indirect re-
generation-inhibiting influence, due to its major struc-
tural role in astroglial cells.
Our data also shed light on mechanisms of vimentin
movement within cells. Live imaging of cells expressing
GFP-vimentin has shown that vimentin is found in com-
plexes of various sizes, which move bidirectionally on
microtubules (Ho et al., 1998; Prahlad et al., 1998; Yoon
et al., 1998). Conventional kinesin is thought to move
vimentin outward toward plus ends of microtubules
(Prahlad et al., 1998), and dynamitin overexpression
was recently used to demonstrate a role for dynein in
inward minus end-directed movement of vimentin on
microtubules (Clarke and Allan, 2002; Helfand et al.,
2002). The direct interaction between vimentin and im-
portin β allows vimentin to connect to dynein via the
association of importins with dynein (Hanz et al., 2003).
Moreover, these findings may rationalize some pre-
viously puzzling reports showing vimentin concentra-
tion in the cell center upon disruption of microtubules
(Clarke and Allan, 2002; Gurland and Gundersen, 1995;
Yoon et al., 1998). Inward clustering of vimentin at the
cell center may be due to interactions of importin β with
nucleoporins. An importin β-nucleoporin interaction
also provides a mechanism for vimentin entry to the
nucleus, strengthening the argument for possible nuclear
roles of vimentin (Traub and Shoeman, 1994). These
findings expand the range of potential roles for vimen-
tin and suggest that intermediate filaments provide dy-
namic and mobile scaffolds for localization and long-
distance transport of signaling molecules within cells.
pErk and Other Signals
in the Regenerative Response
Our data show that vimentin modulates regeneration
in a subset of DRG neurons; however, vimentin is not
expressed in approximately 40% of the neuronal pop-
ulation. Since retrograde transport of pErk in injured
sciatic nerve is completely dependent on vimentin,
other signals most likely substitute or compensate for
pErk in vimentin-negative cells. We have previously
shown that retrograde injury signaling can be inhibitedby excess NLS peptides (Hanz et al., 2003), and since
NLS peptides did not interfere with the vimentin-pErk
interaction, additional signaling molecules are likely
transported by the importin α classical NLS binding site
in the complex. Conversely, a different kinase signal
may be transported instead of pErk in vimentin null
cells; for example, there is evidence for activation of
the jnk pathway in injured rat DRG axons (Kenney and
Kocsis, 1998) and of protein kinase G in lesioned
Aplysia neurons (Sung et al., 2004). Interestingly, trk re-
ceptor activation by NGF leads to retrograde signaling
via Erk5, and not Erk1/2 (Watson et al., 2001). Thus it is
becoming apparent that retrograde signaling occurs via
a diversity of signals, depending on the neuronal sub-
type and type of stimulus.
Although vimentin is known to bind other signaling
molecules, such as PLA2 (Paramio and Jorcano, 2002),
we have focused on the role of vimentin-transported
pErk in lesioned sciatic nerve. How might pErk contrib-
ute to enhanced regeneration of sensory neurons? Two
independent studies have shown that elevation of cAMP
levels in the DRG mimics the regeneration-inducing ef-
fect of a conditioning lesion (Neumann et al., 2002; Qiu
et al., 2002). Cross-talk between the cAMP and Erk
pathways can occur via inhibition of cAMP phospho-
diesterase-4 isoforms by Erk, thus increasing cAMP
levels in the cell (Houslay and Baillie, 2003). Indeed, it
has recently been shown that Erk activated by neuro-
trophin receptors transiently inhibits cAMP phospho-
diesterase-4 in DRG neurons (Gao et al., 2003). The
transient nature of the inhibition may be due to activa-
tion of cAMP-dependent PKA, which in turn can lead
to inhibition of the Erk pathway (Houslay and Baillie,
2003; Maeda et al., 2004). Thus, ongoing elevation of
cAMP in the cell body may require a supply of newly
phosphorylated Erk, provided by vimentin-mediated
trafficking from the axon. It will be interesting to deter-
mine how direct effects of pErk on transcription factors
like Elk1 are combined with indirect effects via cAMP
or other second messengers to coordinate neuronal re-
generation. In this context, it is noteworthy that Liu and
Snider (2001) showed that application of a MEK inhibi-
tor to adult DRG neurons in culture had no effect on
their regenerative outgrowth. In that case, the neurons
underwent conditional lesioning in vivo and were ex-
posed to the MEK inhibitor only afterward in the culture.
Taken together with our findings, this indicates that
pErk is involved in the retrograde signal initiating regen-
eration but is not required during subsequent out-
growth.
Long-Distance Transport of Kinase Signals
This paper has addressed the issue of how kinase sig-
nals might be propagated over long distances within a
cell. Most previous work in this field was on signals
initiated at the plasma membrane by receptor tyrosine
kinases, thus naturally leading to a focus on mecha-
nisms allowing lateral propagation in the membrane or
intracellular trafficking of membrane-enclosed vesicles.
Although soluble complexes of dynein-trafficked mole-
cules have been recognized especially in neurons (Gu-
zik and Goldstein, 2004; Hanz and Fainzilber, 2004; Hir-
okawa and Takemura, 2004), it was not clear how such
Neuron
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Inase while traversing a phosphatase-rich environment.
rWe suggest a mechanism that enables the cell to trans-
s
port an activated kinase over distances of many centi- l
meters in a lesioned axon. A combination of local o
wtranslation and calpain cleavage produces a soluble in-
stermediate filament fragment that may bind the acti-
wvated kinase under high-calcium conditions and re-
lease it with signaling moiety intact upon arrival at a
s
low-calcium region. Linkage of the intermediate fila- a
ment-kinase complex to the retrograde transport ma- d
wchinery is via a cotranslated importin, thus providing
additional specificity to the system. The versatility of
this mechanism suggests that vimentin and pErk may R
Tturn out to be one of many kinase translocation part-
wnerships.
a
wExperimental Procedures
a
βAnimals, In Vivo Procedures, and Cultures
SAdult (8–12 weeks old) male Wistar rats were purchased from Har-
Rlan, Inc. (Rehovot, Israel). Wild-type or vimentin−/− SV129 mice with
wβ-gal inserted at the vimentin locus were generously provided by
ODr. E Colucci-Guyon (Pasteur Institute) and bred and maintained at
2the Veterinary Resources Department of the Weizmann Institute as
spreviously described (Colucci-Guyon et al., 1994). Sciatic nerve
tcrush was performed as previously described (Hanz et al., 2003).
Axoplasm was obtained from freshly dissected nerves after gentle
compression in phosphate-buffered saline (PBS) or in nuclear P
transport buffer (NTB; Hanz et al., 2003) without EGTA, containing S
protease inhibitors (Roche) and 1 mM orthovanadate when neces- p
sary. Purity of axoplasm was verified by Western blotting for i
Schwann cell (S-100) and nuclear (RCC1) markers as described by p
Hanz et al. (2003) and other glial markers as indicated in Figure S1. i
DRG cultures from adult animals were as previously described a
(Hanz et al., 2003). Vimentin trituration into DRGs was carried out t
by introducing 100 g of vimentin to the trituration medium for 15 p
ganglia. Vimentin was prepared for trituration by cleavage with cal- p
pain (100 U; 2 hr). In vivo conditioning sciatic nerve lesions were a
carried out as described by Hanz et al. (2003). For tests of intro- t
duced substances, sciatic nerves were injected concomitantly with c
the crush with the MEK inhibitor UO126 (Biomol; 10 M), the Erk89 v
or Erk312 peptides (250 g), or calpeptin (Calbiochem; 100 M). 3
L4/L5 DRG neurons were cultured 3–5 days after the conditioning N
lesion. Neurons were fixed after 18 hr in culture and stained with s
NFH, and the length of the longest axon per neuron was measured.
In vivo regeneration and recovery of sensory function was tested
Pon wild-type and vimentin null mice following sciatic nerve crush.
HMice were monitored daily for foot withdrawal in response to toe
0pinch of each individual digit with forceps, scored as the percen-
htage of responding digits. Longitudinal sections on injured nerve
awere carried out at designated times and immunostained with anti-
bGAP43 rabbit polyclonal AB5220 (Chemicon). All animal experi-
vmentation was under the supervision of the Weizmann Institute In-
istitutional Animal Care and Use Committee.
p
tAntibodies, Western Blots, and Immunofluorescence
oThe following antibodies were from Chemicon International (Temec-
bula, CA): vimentin monoclonal clone V9 MAB3400; vimentin poly-
pclonal AB1620; peripherin polyclonal AB1530; dynein 74 kDa inter-
mediate chain monoclonal MAB1618; β-gal monoclonal AB1802;
β-gal polyclonal AB1211; NFH polyclonal AB1989; CNPase mo- R
Rnoclonal MAB326. The following antibodies were from Sigma (Re-
hovot, Israel): NFH clone N52 monoclonal; Erk polyclonal M5670; t
sdoubly phosphorylated Erk monoclonal M8159; GFAP clone G-A-5.
The importin β monoclonal antibody 3E9 MA3-070 was from Affinity p
tBioreagents (Golden, CO); β-tubulin polyclonal SC 9104 and lamin
A/C N18 SC 6215 were from Santa Cruz (Santa Cruz, CA); for W
mpElk-1 we used monoclonal 9186 from Cell Signaling (Beverley,
MA); and anti-importin α4 was a kind gift from Dr. Karsten Weis c
w(UC Berkeley). HRP-conjugated secondary antibodies were fromioRad, and fluorescent secondary antibodies were from Jackson
mmunoResearch. Western blots and immunostainings were car-
ied out as described in Hanz et al. (2003). For Westerns, axoplasm
amples were resolved on 10% SDS-PAGE, transferred to nitrocel-
ulose, and after reaction with the desired antibodies were devel-
ped with ECL (Pierce). For immunofluorescence, DRG neurons
ere fixed with 3% paraformaldehyde, while control and injured
ciatic nerve segments were fixed in 4% paraformaldehyde, frozen
ith Tissue-Tek (Sakura, Tokyo), and sectioned longitudinally at 10
m thickness in a Leica cryostat. Neuron cultures and sciatic nerve
ections were mounted in moviol (Calbiochem) and observed under
n Olympus FV500 confocal laser scanning microscope. For Rho-
amine RED-X and Cy5 visualization, we used 543 nm and 633 nm
avelengths in a sequential manner.
ecombinant Expression of pERK and Importin 
o obtain doubly phosphorylated ERK, activated human GST-ERK2
as coexpressed with constitutively active MEK1 in BL21 bacteria,
s previously described (Wilsbacher and Cobb, 2001). The bacteria
ere grown in 2YT medium at 30°C to an optical density of 0.6,
nd then 1 mM IPTG was added for an additional 4 hr. GST-importin
and His-tagged importin β constructs were kindly provided by Dr.
teve Adam (Northwestern University, Chicago, IL) and Dr. Ziv
eich (Weizmann Institute), respectively. Importin β constructs
ere grown in BL21 bacteria in Luria-Bertani medium at 37°C until
D 0.5, followed by overnight incubation with 100 M IPTG at
6°C. Proteins were purified over Glutathione-Sepharose 4B (Amer-
ham Biosciences) or nickel-NTA agarose (Qiagene) according to
he manufacturer’s instructions.
ull-Downs and Coimmunoprecipitations
ciatic nerve axoplasm (500 g) was precleared for 1 hr with 80%
rotein G-Sepharose (Amersham Bioscience). Following overnight
ncubation with primary antibody, complexes were incubated on
rotein G beads for 2 hr, washed extensively, and eluted by boiling
n SDS-PAGE sample buffer before loading on gels for Western blot
nalyses. For coimmunoprecipitation in the presence of competi-
ors, 2 M NLS or reverse-NLS peptides were added to the axo-
lasm for overnight incubation at 4°C. For direct pull-downs, GST-
ERK (0.5 g) or importin β (1 g) were equilibrated in PBS or NTB
nd added to 500 g aliquots of axoplasm from different postlesion
imes. Direct interactions were tested in vitro by mixing 0.1 g re-
ombinant Syrian hamster vimentin or NF (Cytoskeleton Inc., Den-
er, CO) to GST-pERK or GST-importin β and incubated for 2 hr at
7°C. All pull-downs were washed twice with 0.2 M NaCl in PBS or
TB and twice again with PBS or NTB before elution in SDS-PAGE
ample buffer for loading on gels.
hosphatase Protection Assay
is-Imp-β (2 g) was incubated with GST-pERK (0.1 g) and with
–2 g vimentin or NF for 2 hr at 37°C. AP (2 units; Roche, Mann-
eim, Germany) or axoplasm from injured nerve (100 g) was then
dded for an additional 30 min. Complexes were purified over GST
eads followed by Western blot analysis for pERK. AP activity was
erified with the synthetic substrate pNPP (Sigma S0942) dissolved
n 0.1 M glycine buffer (0.1 M glycine, 1 mM MgCl2, 1 mM ZnCl2;
H 10.4) for a stock solution of 1 mg/ml. One unit AP was added
o a reaction mixture consisting of 1 g pNPP with 2 g vimentin
r NF in Tris buffer (pH 7.5) and incubated for 5, 15, and 30 min
efore stopping the reaction with 3 N NaOH. The yellow hydrolysis
roduct was quantified spectrophotometrically at 405 nm.
etrograde Movement
at sciatic nerves were crushed and dissected out at increasing
imes after lesion (0–24 hr). Dissected nerves were divided into con-
ecutive segments of about 10 mm each before extraction of axo-
lasm. From each segment, 300 g axoplasm was immunoprecipi-
ated with the dynein antibody, and precipitates were analyzed by
estern blot for vimentin and pErk. Followup experiments in
ouse were conducted with wild-type or vimentin−/− sciatic nerves,
rushed and ligated as described. At designated times, the nerves
ere dissected, fixed, and sectioned longitudinally over the ligation
Vimentin-Dependent Translocation of Activated Erk
725as previously described (Hanz et al., 2003). Sections were then im-
munostained for pErk and NFH.
pElk1 Response
Rat L4/L5 DRGs were dissected 0–24 hr after sciatic nerve lesion
into lysis buffer (50 mM Tris-HCL [pH 7.4], 150 mM NaCl, 1 mM
PMSF, 1 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail
[Roche]) and processed for Western blot of pErk and pElk-1. For
pElk1 analysis in mouse, DRG processes were lesioned at about
1 mm distance from the ganglia before transfer to PBS and incuba-
tion in vitro for up to 1 hr at 37°C, followed by lysis and Western
blot analysis.
Supplemental Data
The Supplemental Data include two figures and can be found with
this article online at http://www.neuron.org/cgi/content/full/45/5/
715/DC1/.
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